Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Omer Selim Unat"'
Autor:
Ozlem Ulusan Bagci, Filiz Guldaval, Can Muftuoglu, Ufuk Mert, Damla Serce Unat, Omer Selim Unat, Gulru Polat, Seray Toz, Ayse Caner
Publikováno v:
Japanese Journal of Infectious Diseases. 75:569-574
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab4e3407d5a0e12091ed94426f058752
https://doi.org/10.7883/yoken.jjid.2022.288
https://doi.org/10.7883/yoken.jjid.2022.288
Although diagnostic and therapeutic advances in Lung cancer (LC) have increased the survival of patients, infection and its complications are still among the most important causes of mortality. The disruption of tissue caused by tumor mass, managemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9570b2f8395310eb8d728ef6f42e758
https://avesis.deu.edu.tr/publication/details/c68dfe90-4fe2-4e58-8531-80f313041b00/oai
https://avesis.deu.edu.tr/publication/details/c68dfe90-4fe2-4e58-8531-80f313041b00/oai
Autor:
Ozlem Ulusan Bagci, Filiz Guldaval, Can Muftuoglu, Ufuk Mert, Seray Toz, Damla Serce Unat, Omer Selim Unat, Gulru Polat, Ayse Caner
Publikováno v:
Journal of Medical Mycology. 33:101365
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cf5642cd91bbcd56f1eed3a024da756
https://doi.org/10.1016/j.mycmed.2023.101365
https://doi.org/10.1016/j.mycmed.2023.101365
Autor:
Ozlem Ulusan Bagci, Filiz Guldaval, Can Muftuoglu, Ufuk Mert, Damla Serce Unat, Omer Selim Unat, Gulru Polat, Seray Toz, Ayse Caner
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::608c2a793916142cd49f60c279c45752
https://doi.org/10.2139/ssrn.4017115
https://doi.org/10.2139/ssrn.4017115
Autor:
Ömer Selim Unat, Ziya Karimov, Damla Serçe Unat, Gizem Damar, Pakize Çağlayan, Faik Teymurlu, Mehmet Sezai Taşbakan, Pervin Korkmaz Ekren, Özen Başoğlu, Abdullah Sayıner
Publikováno v:
Thoracic Research and Practice, Vol 25, Iss 1, Pp 5-10 (2024)
OBJECTIVE: The optimal anticoagulant treatment regimen in hospitalized coronavirus disease 2019 (COVID-19) patients is uncertain. This study aimed to compare the rates of disease progression and mortality in patients treated with low-molecular-weight
Externí odkaz:
https://doaj.org/article/e30a51fa84c541f888513bffb87d104d